Cargando…
Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer
BACKGROUND: Metastatic cervical squamous cell carcinoma (CSCC) has poor prognosis and is recalcitrant to the current treatment strategies, which warrants the necessity to identify novel prognostic markers and therapeutic targets. Given that CSCC is a virus-induced malignancy, we hypothesized that th...
Autores principales: | Zhang, Yuanyuan, Li, Ning, Yuan, Guangwen, Yao, Hongwen, Zhang, Die, Li, Nan, Zhang, Gongyi, Sun, Yangchun, Wang, Wenpeng, Zeng, Jia, Xu, Ningzhi, Liu, Mei, Wu, Lingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822783/ https://www.ncbi.nlm.nih.gov/pubmed/35130902 http://dx.doi.org/10.1186/s12916-022-02248-w |
Ejemplares similares
-
Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines
por: Velloso, Fernando J., et al.
Publicado: (2018) -
NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Wang, Dongjie
Publicado: (2022) -
Activation of NOD1 and NOD2 in the development of liver injury and cancer
por: Omaru, Naoya, et al.
Publicado: (2022) -
Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
por: Peng, Liang, et al.
Publicado: (2016) -
Retracted: NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Intelligence and Neuroscience, Computational
Publicado: (2023)